Carvedilol inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension
- PMID: 16495763
- DOI: 10.1097/01.fjc.0000201359.58174.c8
Carvedilol inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension
Erratum in
- J Cardiovasc Pharmacol. 2006 Mar;47(3):table of contents
Abstract
Idiopathic pulmonary arterial hypertension (IPAH) is associated with proliferation of smooth muscle cells (SMCs) in small pulmonary arteries. Inhibition of proliferation of pulmonary artery smooth muscle cells (PASMCs) may be an effective treatment of patients with idiopathic pulmonary arterial hypertension. Recent studies have shown that carvedilol, an alpha- and beta-blocker with antioxidant and calcium channel blocking properties, inhibits the proliferation of cultured normal human pulmonary artery smooth muscle cells. In this study, we tested the hypothesis that carvedilol has antiproliferative effects on pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension. Pulmonary artery smooth muscle cells from six idiopathic pulmonary arterial hypertension patients who had undergone lung transplantation were cultured. To determine cell proliferation, H-thymidine incorporation was measured. Platelet-derived growth factor-induced proliferation of IPAH-PASMCs was significantly greater than that of normal control pulmonary artery smooth muscle cells. Carvedilol (0.1 microM to 10 microM) inhibited the proliferation of idiopathic pulmonary arterial hypertension-pulmonary artery smooth muscle cells in a concentration-dependent manner. Prazosin (an alpha-blocker) and N-acetyl L cysteine (an antioxidant agent) (0.1 microM to 10 microM) did not inhibit their proliferation, but the high concentration of propranolol (a beta-blocker) and nifedipine (a calcium channel blocker) (10 microM) inhibited the proliferation. The combination of propranolol and nifedipine inhibited the proliferation but only at a high concentration (10 microM) combination. Cell cycle analysis revealed that carvedilol (10 microM) significantly decreased the number of cells in S and G2/M phases. These results indicate that carvedilol inhibits the exaggerated proliferation of pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension partially via its beta-blocking [corrected] and calcium channel blocking effects in vitro.
Similar articles
-
Inhibitory effects of simvastatin on platelet-derived growth factor signaling in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension.J Cardiovasc Pharmacol. 2010 Jan;55(1):39-48. doi: 10.1097/FJC.0b013e3181c0419c. J Cardiovasc Pharmacol. 2010. PMID: 19786891
-
Prednisolone inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension.Circulation. 2005 Sep 20;112(12):1806-12. doi: 10.1161/CIRCULATIONAHA.105.536169. Epub 2005 Sep 12. Circulation. 2005. PMID: 16157769
-
Carvedilol inhibits vascular smooth muscle cell proliferation.J Cardiovasc Pharmacol. 1993 Feb;21(2):221-7. doi: 10.1097/00005344-199302000-00006. J Cardiovasc Pharmacol. 1993. PMID: 7679155
-
[Molecular Mechanism of Dihydropyridine Ca2+ Channel Blockers in Pulmonary Hypertension].Yakugaku Zasshi. 2016;136(10):1373-1377. doi: 10.1248/yakushi.16-00086. Yakugaku Zasshi. 2016. PMID: 27725386 Review. Japanese.
-
Association between serotonin transporter (SERT) gene polymorphism and idiopathic pulmonary arterial hypertension: a meta-analysis and review of the literature.Metabolism. 2013 Dec;62(12):1867-75. doi: 10.1016/j.metabol.2013.08.012. Epub 2013 Sep 24. Metabolism. 2013. PMID: 24075737 Review.
Cited by
-
Neurohormonal modulation in pulmonary arterial hypertension.Eur Respir J. 2021 Oct 28;58(4):2004633. doi: 10.1183/13993003.04633-2020. Print 2021 Oct. Eur Respir J. 2021. PMID: 33766951 Free PMC article. Review.
-
Treatment of pulmonary arterial hypertension in children.Nat Rev Cardiol. 2015 Apr;12(4):244-54. doi: 10.1038/nrcardio.2015.6. Epub 2015 Feb 3. Nat Rev Cardiol. 2015. PMID: 25645500 Review.
-
Comprehensive analyses of m6A RNA methylation patterns and related immune microenvironment in idiopathic pulmonary arterial hypertension.Front Genet. 2023 Sep 4;14:1222368. doi: 10.3389/fgene.2023.1222368. eCollection 2023. Front Genet. 2023. PMID: 37732317 Free PMC article.
-
3D in vitro Model of Vascular Medial Thickening in Pulmonary Arterial Hypertension.Front Bioeng Biotechnol. 2020 May 20;8:482. doi: 10.3389/fbioe.2020.00482. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32509756 Free PMC article.
-
Epoprostenol sodium for treatment of pulmonary arterial hypertension.Vasc Health Risk Manag. 2015 May 14;11:265-70. doi: 10.2147/VHRM.S50368. eCollection 2015. Vasc Health Risk Manag. 2015. PMID: 25999730 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical